• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. Dec 1985; 50(3): 655–659.
PMCID: PMC261128

Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice.

Abstract

Candida albicans has been shown to stimulate infection in mice by a number of bacteria when both organisms are inoculated intraperitoneally (E. Carlson, Infect. Immun. 39:193-197, 1983). When subcutaneous and intraperitoneal inoculations were given with Staphylococcus aureus and C. albicans injected at opposite sites, mixed infection was established at the site of fungal inoculation but not at the site of the bacterial injection. Histopathologic evaluation of tissues for the presence of C. albicans and S. aureus after intraperitoneal inoculation of both showed fungal growth in the mesentery and omentum of the abdominal cavity. Cocci were numerous and always associated with the fungi, located within the fungal growth rather than at its periphery. It was concluded that this growth pattern in some way protected the bacteria and was the basis for the generalized fungal stimulation of the bacterial infections observed. In addition to C. albicans, Candida stellatoidea, Candida tropicalis, Candida parapsilosis, Torulopsis glabrata, and heat-inactivated C. albicans also demonstrated some ability to protect bacteria injected simultaneously, although C. parapsilosis and T. glabrata were less effective than the other yeasts in this respect.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BENNETT BM. Estimation of LD50 by moving averages. J Hyg (Lond) 1952 Jun;50(2):157–164. [PMC free article] [PubMed]
  • Berger M, Kirkpatrick CH, Goldsmith PK, Gallin JI. IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J Immunol. 1980 Dec;125(6):2437–2443. [PubMed]
  • Carlson E. Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality. Infect Immun. 1982 Dec;38(3):921–924. [PMC free article] [PubMed]
  • Carlson E. Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice. Infect Immun. 1983 Jan;39(1):193–197. [PMC free article] [PubMed]
  • Carlson E. Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect Immun. 1983 Oct;42(1):285–292. [PMC free article] [PubMed]
  • Chappler RR, Maibach HI, Conant MA. Mucocutaneous candidiasis or mucocutaneous microbiosis? JAMA. 1978 Jan 30;239(5):428–429. [PubMed]
  • DOBIAS B. SPECIFIC AND NONSPECIFIC IMMUNITY IN CANDIDA INFECTIONS. EXPERIMENTAL STUDIES OF THE ROLE OF CANDIDA CELL CONSTITUENTS AND REVIEW OF LITERATURE. Acta Med Scand. 1964;176:SUPPL 421–421:1+. [PubMed]
  • JOSSE JW, ZACKS SI. Thymoma and pancytopenia; report of a case and review of the literature. N Engl J Med. 1958 Jul 17;259(3):113–117. [PubMed]
  • KEENEY EL. Candida asthma. Ann Intern Med. 1951 Jan;34(1):223–226. [PubMed]
  • Klotz SA, Drutz DJ, Harrison JL, Huppert M. Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun. 1983 Oct;42(1):374–384. [PMC free article] [PubMed]
  • MANKIEWICZ E, LIVAK M. Effect of Candida albicans on the evolution of experimental tuberculosis. Nature. 1960 Jul 16;187:250–251. [PubMed]
  • MARTIN CM, GORDON RS, MCCULLOUGH NB. Acquired hypogammaglobulinemia in an adult; report of a case, with clinical and experimental studies. N Engl J Med. 1956 Mar 8;254(10):449–456. [PubMed]
  • Morris CA. Influence of oral contraceptives on the presence and persistence of Candida albicans and beta-haemolytic streptococci in the vagina. J Clin Pathol. 1969 Jul;22(4):488–491. [PMC free article] [PubMed]
  • Palestine RF, Su WP, Liesegang TJ. Late-onset chronic mucocutaneous and ocular candidiasis and malignant thymoma. Arch Dermatol. 1983 Jul;119(7):580–586. [PubMed]
  • Staib F, Geier R. Proteolysis products of Candida albicans as a substratum for growth of staphylococcus aureus--a preliminary report. Zentralbl Bakteriol Orig A. 1971 Nov;218(3):374–375. [PubMed]
  • Staib F, Grosse G, Mishra SK. Staphylococcus aureus and Candida albicans infection (animal experiments). Zentralbl Bakteriol Orig A. 1976 May;234(4):450–461. [PubMed]
  • Trier JS, Bjorkman DJ. Esophageal, gastric, and intestinal candidiasis. Am J Med. 1984 Oct 30;77(4D):39–43. [PubMed]
  • Wachs GN. Monilial granuloma (Candida). Arch Dermatol. 1970 Jan;101(1):118–119. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...